Mathieu Drouin

1.1k total citations
19 papers, 312 citations indexed

About

Mathieu Drouin is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Mathieu Drouin has authored 19 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Mathieu Drouin's work include Virus-based gene therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and RNA Interference and Gene Delivery (4 papers). Mathieu Drouin is often cited by papers focused on Virus-based gene therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and RNA Interference and Gene Delivery (4 papers). Mathieu Drouin collaborates with scholars based in Canada and United States. Mathieu Drouin's co-authors include Daniel Jung, Marie‐Pierre Cayer, Daniel Agudelo, Lusiné Bozoyan, Graham Dellaire, Jayme Salsman, Jérémy Loehr, Josée Laganière, Caroline Huard and Sophie Carter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Methods and Virology.

In The Last Decade

Mathieu Drouin

17 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Drouin Canada 10 195 76 59 47 39 19 312
Rick van Nuland Netherlands 6 362 1.9× 44 0.6× 36 0.6× 18 0.4× 28 0.7× 8 444
Christine M. Barbon United States 9 164 0.8× 115 1.5× 65 1.1× 112 2.4× 21 0.5× 15 428
Sai A. Patibandla United States 12 132 0.7× 35 0.5× 25 0.4× 68 1.4× 72 1.8× 18 348
Robert S. Topping United States 8 286 1.5× 22 0.3× 22 0.4× 35 0.7× 46 1.2× 8 381
Libing Mu China 8 193 1.0× 14 0.2× 49 0.8× 77 1.6× 22 0.6× 10 315
Philip Homan United States 10 304 1.6× 36 0.5× 52 0.9× 69 1.5× 12 0.3× 14 397
Weili Jin China 6 147 0.8× 26 0.3× 23 0.4× 125 2.7× 79 2.0× 9 350
Eva‐Maria König Germany 10 66 0.3× 32 0.4× 49 0.8× 19 0.4× 29 0.7× 15 247
Bala S. Balakumaran United States 10 239 1.2× 55 0.7× 52 0.9× 36 0.8× 33 0.8× 12 346
Richard Kirkman United States 11 221 1.1× 63 0.8× 46 0.8× 57 1.2× 22 0.6× 18 379

Countries citing papers authored by Mathieu Drouin

Since Specialization
Citations

This map shows the geographic impact of Mathieu Drouin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Drouin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Drouin more than expected).

Fields of papers citing papers by Mathieu Drouin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Drouin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Drouin. The network helps show where Mathieu Drouin may publish in the future.

Co-authorship network of co-authors of Mathieu Drouin

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Drouin. A scholar is included among the top collaborators of Mathieu Drouin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Drouin. Mathieu Drouin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Drouin, Mathieu, et al.. (2023). Prevalence of weak D phenotypes in the general population of Québec, Canada: A focus on weak D type 42. Vox Sanguinis. 118(7). 577–581.
2.
Lewin, Antoine, Gaston De Serres, Yves Grégoire, et al.. (2022). Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study. Canadian Journal of Public Health. 113(3). 385–393. 4 indexed citations
3.
Anand, Sai Priya, Jérémie Prévost, Jonathan Richard, et al.. (2021). High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samples. Transfusion. 61(5). 1377–1382. 13 indexed citations
4.
Lewin, Antoine, Gaston De Serres, Yves Grégoire, et al.. (2021). SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study. Canadian Journal of Public Health. 112(4). 576–586. 18 indexed citations
5.
Fröhlich, Thomas, et al.. (2018). A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects. SHILAP Revista de lepidopterología. 4(1). 2 indexed citations
6.
Agudelo, Daniel, Lusiné Bozoyan, Caroline Huard, et al.. (2017). Marker-free coselection for CRISPR-driven genome editing in human cells. Nature Methods. 14(6). 615–620. 110 indexed citations
7.
Loubaki, Lionel, Dominique Chabot, Isabelle Paré, Mathieu Drouin, & Renée Bazin. (2017). MiR-146a potentially promotes IVIg-mediated inhibition of TLR4 signaling in LPS-activated human monocytes. Immunology Letters. 185. 64–73. 17 indexed citations
8.
Agudelo, Daniel, Lusiné Bozoyan, Caroline Huard, et al.. (2017). A marker-free co-selection strategy for high efficiency homology-driven and NHEJ-based gene editing in human cells. Protocol Exchange. 1 indexed citations
9.
Skrypnyk, Nataliya, Paul Voziyan, Haichun Yang, et al.. (2016). Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury. American Journal of Physiology-Renal Physiology. 311(2). F268–F277. 29 indexed citations
10.
Cayer, Marie‐Pierre, et al.. (2011). Suppression of protein phosphatase 2A activity enhances Ad5/F35 adenovirus transduction efficiency in normal human B lymphocytes and in Raji cells. Journal of Immunological Methods. 376(1-2). 113–124. 5 indexed citations
11.
Drouin, Mathieu, Marie‐Pierre Cayer, & Daniel Jung. (2010). Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor. Virology. 401(2). 305–313. 16 indexed citations
12.
Cayer, Marie‐Pierre, et al.. (2010). Overexpression of PAX5 induces apoptosis in multiple myeloma cells. International Journal of Hematology. 92(3). 451–462. 17 indexed citations
13.
Cayer, Marie‐Pierre, et al.. (2010). 2-Methoxyestradiol induce the conversion of human peripheral blood memory B lymphocytes into plasma cells. Journal of Immunological Methods. 355(1-2). 29–39. 8 indexed citations
14.
15.
Cayer, Marie‐Pierre, Mathieu Drouin, Audrey Forest, et al.. (2007). Comparison of promoter activities for efficient expression into human B cells and haematopoietic progenitors with adenovirus Ad5/F35. Journal of Immunological Methods. 322(1-2). 118–127. 11 indexed citations
16.
Jung, Daniel, et al.. (2005). Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector AD5/F35. Journal of Immunological Methods. 304(1-2). 78–87. 22 indexed citations
17.
Drouin, Mathieu, et al.. (2004). Maintenance of Epstein–Barr virus-derived episomal vectors in the murine Sp2/0 myeloma cell line is dependent upon exogenous expression of human EBP2. Biochemistry and Cell Biology. 82(3). 375–380. 2 indexed citations
18.
Jung, Daniel, Serge Côté, Mathieu Drouin, Carl Simard, & Réal Lemieux. (2002). Inducible expression of Bcl‐XL restricts apoptosis resistance to the antibody secretion phase in hybridoma cultures. Biotechnology and Bioengineering. 79(2). 180–187. 28 indexed citations
19.
Dumont, Larry J. & Mathieu Drouin. (1954). [Histochemical determination of acetyl-cholinesterase in the myocardium].. PubMed. 238(2). 274–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rick van Nuland Breakdown of academic impact, for papers by Christine M. Barbon Breakdown of academic impact, for papers by Sai A. Patibandla Breakdown of academic impact, for papers by Robert S. Topping Breakdown of academic impact, for papers by Libing Mu Breakdown of academic impact, for papers by Philip Homan Breakdown of academic impact, for papers by Weili Jin Breakdown of academic impact, for papers by Eva‐Maria König Breakdown of academic impact, for papers by Bala S. Balakumaran Breakdown of academic impact, for papers by Richard Kirkman
Rankless by CCL
2026